| Literature DB >> 32355025 |
Wouter R Karthaus1, Matan Hofree2, Danielle Choi1, Eliot L Linton1, Mesruh Turkekul3, Alborz Bejnood2, Brett Carver1, Anuradha Gopalan1, Wassim Abida1, Vincent Laudone1, Moshe Biton2, Ojasvi Chaudhary4, Tianhao Xu4, Ignas Masilionis4, Katia Manova3, Linas Mazutis4, Dana Pe'er4,5, Aviv Regev6,7,8, Charles L Sawyers9,7.
Abstract
Androgen deprivation is the cornerstone of prostate cancer treatment. It results in involution of the normal gland to ~90% of its original size because of the loss of luminal cells. The prostate regenerates when androgen is restored, a process postulated to involve stem cells. Using single-cell RNA sequencing, we identified a rare luminal population in the mouse prostate that expresses stemlike genes (Sca1 + and Psca +) and a large population of differentiated cells (Nkx3.1 +, Pbsn +). In organoids and in mice, both populations contribute equally to prostate regeneration, partly through androgen-driven expression of growth factors (Nrg2, Rspo3) by mesenchymal cells acting in a paracrine fashion on luminal cells. Analysis of human prostate tissue revealed similar differentiated and stemlike luminal subpopulations that likewise acquire enhanced regenerative potential after androgen ablation. We propose that prostate regeneration is driven by nearly all persisting luminal cells, not just by rare stem cells.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32355025 PMCID: PMC7313621 DOI: 10.1126/science.aay0267
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728